Supplementary MaterialsSupplementary Desk 1. al., 2020; Wang et al., 2020). Starting from December 2019, SARS-CoV-2 led to a worldwide COVID-19 pandemic, which caused more than 3 million cases along with more than 250,000 deaths within 5 months1. The first case of COVID-19 in Turkey was announced in L-(-)-Fucose March 11th and as of May 24th, the real amount of positive instances and fatalities reached to 156,827 and 4,340, respectively2. A complete of 63 sequences from SARS-CoV-2 isolates of Turkey had been published to global effort on posting all influenza data (GISAID) data source between the times March 25th and could 22nd3. The purpose of this research can be to reveal the most frequent mutations of SARS-CoV-2 viral isolates from Turkey compared to the research series from China (“type”:”entrez-nucleotide”,”attrs”:”text”:”NC_045512.1″,”term_id”:”1796318596″,”term_text”:”NC_045512.1″NC_045512.1). Our outcomes revealed that a number of the viral mutations can be found in a lot more than 60% from the isolates. Although further evaluation and characterizations are required, the data with this scholarly research may donate to understanding the molecular evolution of SARS-CoV-2 in Turkey. 2. Methods and Materials 2.1. Dataset building All of the SARS-CoV-2 entire genome sequences have already been downloaded from GISAID data source3 (Elbe and Buckland-Merrett, 2017; McCauley and Shu, 2017). The complete genome series dataset was built as including 63 viral sequences from Turkish individuals that were posted to the data source between March 25th and May22nd, 2020 (Supplementary Desk 1) as well as the research SARS-CoV-2 series isolated in Wuhan that was downloaded from GeneBank (“type”:”entrez-nucleotide”,”attrs”:”text”:”NC_045512.1″,”term_id”:”1796318596″,”term_text”:”NC_045512.1″NC_045512.1)4. Among the sequences (EPI_ISL_435057) was excluded through the evaluation because of harboring extreme amount of exclusive mutations, that may derive from sequencing mistakes. Desk 1 Common nucleotide substitutions in 62 SARS-CoV-2 viral genomes L-(-)-Fucose fromTurkey (posted to GISAID between March 25th and could 22nd 2020) compared to the SARS-CoV-2 NCBI reference genome NC 045512.1. The viral gene and gene products were identified according to the reference sequence information from GeneBank4. The nucleotide sequences were indicated starting from the 5 UTR, while the corresponding amino acid changes were mentioned separately for each protein coding region specific for the corresponding protein. assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429866AfyonFemale522020-03-162020-04-24Patient travelled to Saudi ArabiaIlluminaMiseq br / Assembly: Burrows-Wheeler Aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429865?anakkaleFemale722020-03-182020-04-24NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429864SakaryaMale332020-03-222020-04-24NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429863SakaryaFemale422020-03-222020-04-24NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429862AnkaraMale652020-03-222020-04-24Patient travelled to Saudi ArabiaIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_429861AnkaraMale482020-03-222020-04-24NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428723AksarayMale482020-03-222020-04-21Patient travelled to Saudi ArabiaIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428722Bal?kesirFemale372020-03-222020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428721AnkaraMaleNA2020-03-212020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428720AnkaraFemale352020-03-212020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / L-(-)-Fucose 1,000x coverageEPI_ISL_428719SiirtMale522020-03-212020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428718KocaeliMale352020-03-192020-04-21Patient travelled to Saudi ArabiaIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428717KocaeliMale382020-03-192020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428716AnkaraFemale622020-03-182020-04-21Patient travelled to Saudi ArabiaIllumina Miseq ENOX1 br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428715Nev?ehirFemale552020-03-182020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428714KastamonuMale602020-03-182020-04-21Patient travelled to Saudi ArabiaIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428713AnkaraFemaleNA2020-03-182020-04-21NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428712KaramanMale722020-03-172020-04-21Patient travelled to FranceIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 1,000x coverageEPI_ISL_428368?stanbulFemale492020-04-162020-04-20NAIlluminaNextSeq br / Assembly: BWA-MEM1,750x coverageEPI_ISL_428346?stanbulMale492020-04-172020-04-20NAIllumina Next Seq br / assembly: BWA-MEM 2,350x coverageEPI_ISL_427391?stanbulMale512020-04-132020-04-18NAIllumina Next Seq br / assembly: BWA-MEM 0.7.17.15,845x coverageEPI_ISL_424366KayseriMale822020-03-172020-04-13NAIllumina Miseq br / assembly: Burrows-Wheeler aligner br / v.07.17-r1188 br / 26,200x coverageEPI_ISL_417413NAFemale272020-03-172020-03-25NANanopore MinIONGeneious Primary245X coverageEPI_ISL_435057Ad?yamanMale802020-04-092020-05-02NAOxford Nanopore MinION assembly: Geneious Primary 2020.1.240X coverageEPI_ISL_437304Nev?ehirFemale542020-03-262020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437305KocaeliFemale662020-03-272020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437306KocaeliMale302020-03-272020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437307MardinFemale192020-03-252020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437308AnkaraMale542020-03-252020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437309AnkaraFemale582020-03-262020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437310AnkaraMaleNA2020-03-272020-05-08NAOxford Nanopore GridION br / assembly: Geneious Primary1000X coverageEPI_ISL_437311AnkaraMale612020-03-272020-05-08NAOxford Nanopore GridION br / assembly: L-(-)-Fucose Geneious Primary1000X coverageEPI_ISL_437312KocaeliMale522020-03-252020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437313KocaeliMale492020-03-272020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437314AnkaraMale622020-03-262020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437315AnkaraFemale332020-03-262020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437316DenizliFemaleNA2020-03-252020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437317AnkaraFemale582020-03-272020-05-08Patient travelled to Saudi ArabiaOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437318AnkaraMale312020-03-192020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437319KocaeliMale472020-03-192020-05-08Patient L-(-)-Fucose travelled to IranOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437320?stanbulFemale412020-03-192020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437321?stanbulFemale252020-03-192020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437322AnkaraFemale622020-03-192020-05-08NAOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437323?stanbulMale412020-03-192020-05-08Patient travelled toTaiwanOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437324?stanbulMale272020-03-192020-05-08Patient travelled to IranOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437325?stanbulMale442020-03-192020-05-08Patient travelled to IranOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437326?stanbulMale382020-03-192020-05-08Patient travelled to IranOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437327A?r?Feminine352020-03-192020-05-08Patient travelled to IranOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437328Tekirda?Feminine352020-03-192020-05-08Patient travelled to Saudi ArabiaOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437329AnkaraMale312020-03-192020-05-08Patient travelled to Saudi ArabiaOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437330TokatMale202020-03-192020-05-08Health workerOxford Nanopore GridION br / assembly: Geneious Leading1000X coverageEPI_ISL_437331AnkaraFemale592020-03-252020-05-08Patient travelled to Saudi ArabiaOxford Nanopore GridION.